FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression.
24 Apr 15:33 · 10News
FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression.
24 Apr 15:33 · ABC15 Arizona
FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication o
24 Apr 14:16 · The Washington Times
FDA plans ultra-fast review of three psychedelic drugs following Trump directive
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression.
24 Apr 07:05 · The Seattle Times
last updated on 25 Apr 09:17